AOP-Wiki

API

All KERs

Showing 1001 to 1025 of 3002 KERs

ID	Upstream Event	Downstream Event	Creation Date	Last Updated	AOPs

1009	994: Decreased, Synthesis of molting fluid proteases	996: Decrease, Digestion of old cuticle	Nov 29, 2016	Dec 3, 2016	None
730	743: Decreased, Testosterone binding to androgen receptor (hypothalamus)	744: Increase, Hyperplasia (Leydig cells)	Nov 29, 2016	Dec 3, 2016	None
744	743: Decreased, Testosterone binding to androgen receptor (hypothalamus)	754: Increased, Luteinizing hormone (LH)	Nov 29, 2016	Dec 3, 2016	1 AOP 111: Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)
1142	1093: Decreased, Thyroxine (T4) in tissues	1101: Altered, Amphibian metamorphosis	Nov 29, 2016	Dec 3, 2016	None
1163	1093: Decreased, Thyroxine (T4) in tissues	1116: Decreased, Triiodothyronine (T3) in tissues	Nov 29, 2016	Dec 3, 2016	None
1027	1003: Decreased, Triiodothyronine (T3)	1004: Reduced, Posterior swim bladder inflation	Nov 29, 2016	Oct 7, 2022	2 AOPs 155: Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation 157: Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation
1035	1003: Decreased, Triiodothyronine (T3)	1007: Reduced, Anterior swim bladder inflation	Nov 29, 2016	Oct 7, 2022	3 AOPs 156: Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation 158: Deiodinase 1 inhibition leading to increased mortality via reduced anterior swim bladder inflation 159: Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation
2373	1003: Decreased, Triiodothyronine (T3)	1877: Altered, retinal layer structure	May 11, 2021	Jul 8, 2022	1 AOP 363: Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure
2376	1003: Decreased, Triiodothyronine (T3)	1878: Decreased, Eye size	May 11, 2021	Jun 16, 2021	1 AOP 364: Thyroperoxidase inhibition leading to altered visual function via decreased eye size
2378	1003: Decreased, Triiodothyronine (T3)	1640: Altered, Photoreceptor patterning	May 11, 2021	Oct 17, 2021	1 AOP 365: Thyroperoxidase inhibition leading to altered visual function via altered photoreceptor patterning
1164	1116: Decreased, Triiodothyronine (T3) in tissues	1101: Altered, Amphibian metamorphosis	Nov 29, 2016	Dec 3, 2016	1 AOP 189: Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis
2238	1116: Decreased, Triiodothyronine (T3) in tissues	1023: Increased, Thyroid-stimulating hormone (TSH)	Dec 9, 2020	Dec 9, 2020	1 AOP 190: Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis
2239	1116: Decreased, Triiodothyronine (T3) in tissues	1829: Altered, TH-dependent gene expression	Dec 9, 2020	Dec 9, 2020	1 AOP 190: Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis
768	737: Decreased, Uptake of inorganic iodide	771: Decrease, Serum thyroid hormone (T4/T3)	Nov 29, 2016	Dec 3, 2016	None
2421	737: Decreased, Uptake of inorganic iodide	277: TH synthesis, Decreased	Jul 7, 2021	Jul 7, 2021	None
334	304: Decreased, VegfR2	305: Inhibition, VegfR2	Nov 29, 2016	Dec 3, 2016	None
2938	2147: Decreased, Viable Offspring	360: Decrease, Population growth rate	Jun 2, 2023	Sep 29, 2023	1 AOP 323: PPARalpha Agonism Leading to Decreased Viable Offspring via Decreased 11-Ketotestosterone
1383	1295: Defect of Embryogenesis	1277: Reproductive failure	Feb 15, 2017	Feb 15, 2017	1 AOP 210: Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building
907	890: Degeneration of dopaminergic neurons of the nigrostriatal pathway	188: Neuroinflammation	Nov 29, 2016	Oct 2, 2017	1 AOP 3: Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
910	890: Degeneration of dopaminergic neurons of the nigrostriatal pathway	896: Parkinsonian motor deficits	Nov 29, 2016	Oct 3, 2025	5 AOPs 3: Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits 587: Inhibition of the mitochondrial complex III of nigro-striatal neurons leads to parkinsonian motor deficits 588: Inhibition of the mitochondrial complex II of nigro-striatal neurons leads to parkinsonian motor deficits 589: Inhibition of the mitochondrial complex IV of nigro-striatal neurons leads to parkinsonian motor deficits 593: Redox cycling of a chemical by mitochondria leads to degeneration of nigrostriatal dopaminergic neurons
3077	890: Degeneration of dopaminergic neurons of the nigrostriatal pathway	637: impaired, Learning and memory	Oct 17, 2023	Oct 17, 2023	1 AOP 471: Various neuronal effects induced by elavl3, sox10, and mbp
447	428: Delay, Developmental GABA shift	385: Synaptogenesis, Decreased	Nov 29, 2016	Dec 3, 2016	None
2739	2047: Delay, Ovarian maturation	2048: Increase, Body volume of female adults	Aug 28, 2022	Aug 28, 2022	1 AOP 465: Alcohol dehydrogenase leading to reproductive dysfunction
2740	2047: Delay, Ovarian maturation	2049: Increase, sex ratio (F/M)	Aug 28, 2022	Aug 28, 2022	1 AOP 465: Alcohol dehydrogenase leading to reproductive dysfunction
1182	1140: Delayed, Sexual maturity	1141: Decreased, Reproductive Success	Nov 29, 2016	Dec 3, 2016	None

Key Event Relationships (KERs)

All KERs